tiprankstipranks
Promising Clinical Data and Financial Stability Support Buy Rating for Tenaya Therapeutics Despite Price Target Reduction
PremiumRatingsPromising Clinical Data and Financial Stability Support Buy Rating for Tenaya Therapeutics Despite Price Target Reduction
16d ago
Tenaya Therapeutics price target lowered to $6 from $18 at Canaccord
Premium
The Fly
Tenaya Therapeutics price target lowered to $6 from $18 at Canaccord
16d ago
Buy Rating for Tenaya Therapeutics: Strong Clinical Progress and Financial Stability
Premium
Ratings
Buy Rating for Tenaya Therapeutics: Strong Clinical Progress and Financial Stability
16d ago
Tenaya Therapeutics price target lowered to $5 from $18 at H.C. Wainwright
PremiumThe FlyTenaya Therapeutics price target lowered to $5 from $18 at H.C. Wainwright
18d ago
Promising Clinical Developments and Strategic Advancements Support Buy Rating for Tenaya Therapeutics
Premium
Ratings
Promising Clinical Developments and Strategic Advancements Support Buy Rating for Tenaya Therapeutics
18d ago
Tenaya Therapeutics reports Q4 EPS (28c), consensus (31c)
Premium
The Fly
Tenaya Therapeutics reports Q4 EPS (28c), consensus (31c)
18d ago
Tenaya Therapeutics 75M share Spot Secondary priced at 70c
PremiumThe FlyTenaya Therapeutics 75M share Spot Secondary priced at 70c
25d ago
Tenaya Therapeutics announces common stock, warrants offering
Premium
The Fly
Tenaya Therapeutics announces common stock, warrants offering
25d ago
Tenaya Therapeutics Appoints Interim Accounting Officer
Premium
Company Announcements
Tenaya Therapeutics Appoints Interim Accounting Officer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100